Showing results (1-10 of 249) with videos related to
Sort By:
Pageof 25
Journal of Neuroimmunology|June 7, 2006
Effects of interferon-beta on oligodendroglial cellsSandra Heine, Jens Ebnet, Samaneh Maysami, et al.Journal of Neuroimmunology|July 11, 2006
Oligodendrocyte precursor cells express a functional chemokine receptor CCR3: implications for myelinationSamaneh Maysami, Dan Nguyen, Franziska Zobel, et al.Neuroreport|July 14, 2006
Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12Samaneh Maysami, Dan Nguyen, Franziska Zobel, et al.Glia|April 30, 2008
The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelinationMaren Lindner, Corinna Trebst, Sandra Heine, et al.Acta Neuropathologica|October 18, 2007
Lack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelinationCorinna Trebst, Sandra Heine, Stefan Lienenklaus, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 6, 2008
Proliferating progenitor cells: a required cellular element for induction of ischemic tolerance in the brainSamaneh Maysami, Jin Quan Lan, Manabu Minami, et al.Therapeutic Advances in Neurological Disorders|December 25, 2010
New advances in the treatment of neurological diseases using high dose intravenous immunoglobulinsMartin StangelNature Reviews. Neurology|June 6, 2009
Multiple sclerosis: Hematopoietic stem cell transplantation: hope and hypeMartin StangelExpert Opinion on Investigational Drugs|April 23, 2004
Remyelinating and neuroprotective treatments in multiple sclerosisMartin StangelCurrent Pharmaceutical Design|May 23, 2012
Neurodegeneration and neuroprotection in multiple sclerosisMartin StangelPageof 25